Echocardiographic findings in COVID-19 patients with cardiovascular disease

Abstract

Background: COVID-19 has rapidly spread around the world and threatened global health. Although this disease mainly affects the respiratory system, there is increasing evidence that SARS-CoV-2 also has effects on the cardiovascular system. Echocardiography is a valuable tool in the assessment of cardiovascular disease. Purpose: The study’s purpose was to investigate the echocardiographic parameters in COVID-19 patients with cardiovascular disease (CVD). Methods: Eighty-two patients (males, 54%; mean age, 64 ± 12 years) who were confirmed COVID-19 infection were enrolled in this study. Fourty (48.7%) patients had underlying CVD. Echocardiography was performed in all patients for evaluation of cardiac function. Results: Size of right atrium (38.3 ± 4.7; 33.6 ± 4.5 mm) and right ventricle outflow tract (36.7 ± 4.4; 33.2 ± 4.1 mm), mitral E/Ea ratio (9.8 ± 3.1; 8.4 ± 2.7) were increased, whereas TAPSE (20.2 ± 3.9; 22.6 ± 3.5 mm) was decreased in patients with CVD compared with those without CVD. Conclusion: The most frequent echocardiographic findings in COVID-19 patients with CVD was impaired systolic function of right ventricle and diastolic function of left ventricle.